SI1197223T1 - - Google Patents

Info

Publication number
SI1197223T1
SI1197223T1 SI200030651T SI200030651T SI1197223T1 SI 1197223 T1 SI1197223 T1 SI 1197223T1 SI 200030651 T SI200030651 T SI 200030651T SI 200030651 T SI200030651 T SI 200030651T SI 1197223 T1 SI1197223 T1 SI 1197223T1
Authority
SI
Slovenia
Prior art keywords
retinopathy
angiotensin
treating
salt
development
Prior art date
Application number
SI200030651T
Other languages
English (en)
Inventor
Shizue Nakagawa
Yasutaka Nagisa
Hitoshi Ikeda
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of SI1197223T1 publication Critical patent/SI1197223T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
SI200030651T 1999-04-28 2000-04-27 SI1197223T1 (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP12149899 1999-04-28
PCT/JP2000/002766 WO2000066161A1 (fr) 1999-04-28 2000-04-27 Preventifs / remedes / inhibiteurs de progression pour retinopathie simplex ou retinopathie preproliferante
EP00921056A EP1197223B1 (en) 1999-04-28 2000-04-27 Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy

Publications (1)

Publication Number Publication Date
SI1197223T1 true SI1197223T1 (xx) 2005-08-31

Family

ID=14812676

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030651T SI1197223T1 (xx) 1999-04-28 2000-04-27

Country Status (23)

Country Link
US (2) US7064141B1 (xx)
EP (1) EP1197223B1 (xx)
KR (1) KR100865059B1 (xx)
CN (1) CN1172719C (xx)
AT (1) ATE289204T1 (xx)
AU (1) AU774799B2 (xx)
BR (1) BR0010084A (xx)
CA (1) CA2371554C (xx)
CZ (1) CZ301913B6 (xx)
DE (1) DE60018186T2 (xx)
DK (1) DK1197223T3 (xx)
ES (1) ES2233362T3 (xx)
HU (1) HU226948B1 (xx)
MX (1) MXPA01010923A (xx)
NO (1) NO327446B1 (xx)
NZ (1) NZ514855A (xx)
PL (1) PL196895B1 (xx)
PT (1) PT1197223E (xx)
RU (1) RU2239454C2 (xx)
SI (1) SI1197223T1 (xx)
SK (1) SK286859B6 (xx)
WO (1) WO2000066161A1 (xx)
ZA (1) ZA200108527B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4484427B2 (ja) * 2001-12-03 2010-06-16 武田薬品工業株式会社 インスリン抵抗性改善剤
WO2003047573A1 (fr) * 2001-12-03 2003-06-12 Takeda Chemical Industries, Ltd. Agents pour améliorer l'état de résistance à l'insuline
TW200304812A (en) * 2002-03-08 2003-10-16 Sankyo Co An eye drop containing a tetrazole derivative
US8980870B2 (en) 2002-09-24 2015-03-17 Boehringer Ingelheim International Gmbh Solid telmisartan pharmaceutical formulations
DE10335027A1 (de) * 2003-07-31 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Angiotensin II Rezeptor Antagonisten
BRPI0409293A (pt) * 2003-04-15 2006-04-11 Sankyo Co medicamento para a prevenção ou tratamento de doenças angiogênicas intraoculares
US20050038093A1 (en) * 2003-05-02 2005-02-17 Boehringer Ingelheim International Gmbh Treating diabetic retinopathy with angiotensin II receptor blockers
KR20070083538A (ko) 2004-08-31 2007-08-24 뉴사우스 이노베이션즈 피티와이 리미티드 Ｖｅｇｆ 억제
EA013053B1 (ru) * 2004-11-05 2010-02-26 Бёрингер Ингельхайм Интернациональ Гмбх Двуслойная таблетка, содержащая телмисартан и амлодипин
DK1872783T3 (da) * 2005-04-21 2012-04-23 Santen Pharmaceutical Co Ltd Terapeutisk middel til corneale/conjunctivale lidelser
RU2423127C2 (ru) * 2005-12-06 2011-07-10 Сантен Фармасьютикал Ко., Лтд. Терапевтическое средство против роговично-конъюнктивального нарушения
EA016593B1 (ru) * 2007-03-28 2012-06-29 Такеда Фармасьютикал Компани Лимитед ТВЕРДАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ ПРОИЗВОДНОЕ БЕНЗИМИДАЗОЛ-7-КАРБОКСИЛАТА И pH РЕГУЛИРУЮЩИЙ АГЕНТ

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027211D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
US5591762A (en) 1991-02-06 1997-01-07 Dr. Karl Thomae Gmbh Benzimidazoles useful as angiotensin-11 antagonists
DE4201554A1 (de) 1992-01-22 1993-07-29 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9110635D0 (en) 1991-05-16 1991-07-03 Glaxo Group Ltd Chemical compounds
IL104755A0 (en) * 1992-02-17 1993-06-10 Ciba Geigy Ag Treatment of glaucoma
GB9223860D0 (en) 1992-11-13 1993-01-06 Glaxo Group Ltd Chemical compounds
CZ154994A3 (en) 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
JPH0789957A (ja) 1993-09-22 1995-04-04 Nissan Chem Ind Ltd ビフェニルメチルアミン誘導体
JPH09508641A (ja) * 1994-02-08 1997-09-02 チバーガイギー アクチエンゲゼルシャフト アンギオテンシン▲ｉｉ▼拮抗薬による正常眼圧緑内障の治療
JPH09210183A (ja) * 1996-01-31 1997-08-12 Suzuki Motor Corp 動力伝達装置
TR199801954T2 (xx) * 1996-03-29 1998-12-21 Smithkline Beecham Corporation Eprosartan dihidrat ve �retimi ve form�lasyonu i�in bir proses.
PL189066B1 (pl) * 1996-04-05 2005-06-30 Takeda Pharmaceutical Kompozycja farmaceutyczna do zapobiegania lub zwalczania chorób związanych z angiotensyną II oraz stosowanie związków do wytwarzania leku do zapobiegania lub zwalczania chorób związanych z angiotensyną II
TW416953B (en) 1996-09-25 2001-01-01 Takeda Chemical Industries Ltd Tricyclic compounds for eliciting a prostaglandin I2 receptor agonistic effect, their production and use
EP0855392A3 (de) * 1997-01-22 2000-01-05 Hoechst Aktiengesellschaft Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0991647B1 (en) 1997-06-27 2002-09-04 Smithkline Beecham Corporation Eprosartan monohydrate
IT1292437B1 (it) 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
KR100508044B1 (ko) * 1997-08-06 2005-08-17 스미스클라인 비참 코포레이션 에프로사르탄 아르기닌 전하-중화-복합체와 그의 제조 및제형화 방법
ATE258430T1 (de) 1998-03-04 2004-02-15 Takeda Chemical Industries Ltd Zubereitung mit verzögerter wirkstoffabgabe für aii antagonisten, ihre herstellung und verwendung
RU2243768C2 (ru) * 1998-07-10 2005-01-10 Новартис Аг Гипотензивная комбинация валсартана и блокатора кальциевых каналов
FR2783422A1 (fr) 1998-09-21 2000-03-24 Sanofi Sa Composition pharmaceutique contenant un antagoniste des recepteurs at1 de l'angiotensine ii et un antiagregant plaquettaire
JP2000159671A (ja) 1998-12-01 2000-06-13 Takeda Chem Ind Ltd 血管新生阻害剤

Also Published As

Publication number Publication date
KR100865059B1 (ko) 2008-10-23
EP1197223A1 (en) 2002-04-17
US7064141B1 (en) 2006-06-20
ATE289204T1 (de) 2005-03-15
PT1197223E (pt) 2005-04-29
EP1197223A4 (en) 2003-10-29
DE60018186D1 (de) 2005-03-24
DE60018186T2 (de) 2005-12-29
CA2371554C (en) 2009-06-09
HUP0200890A3 (en) 2002-12-28
US20060189669A1 (en) 2006-08-24
ES2233362T3 (es) 2005-06-16
BR0010084A (pt) 2002-01-15
AU774799B2 (en) 2004-07-08
NO20015257D0 (no) 2001-10-26
NO20015257L (no) 2001-10-26
CZ301913B6 (cs) 2010-07-28
MXPA01010923A (es) 2002-06-21
KR20020015315A (ko) 2002-02-27
EP1197223B1 (en) 2005-02-16
PL350554A1 (en) 2002-12-16
CA2371554A1 (en) 2000-11-09
DK1197223T3 (da) 2005-05-30
CN1172719C (zh) 2004-10-27
ZA200108527B (en) 2002-10-17
HU226948B1 (en) 2010-03-29
RU2239454C2 (ru) 2004-11-10
CZ20013804A3 (cs) 2002-04-17
WO2000066161A1 (fr) 2000-11-09
NZ514855A (en) 2004-01-30
SK15452001A3 (sk) 2002-04-04
SK286859B6 (sk) 2009-06-05
HUP0200890A2 (hu) 2002-11-28
PL196895B1 (pl) 2008-02-29
NO327446B1 (no) 2009-06-29
CN1348385A (zh) 2002-05-08
AU4143400A (en) 2000-11-17

Similar Documents

Publication Publication Date Title
GB9801690D0 (en) Therapeutic agents
HK1061852A1 (en) 4,5-dihydro-ih-pyrazole derivatives having cb1-antagonistic activity
AU2864002A (en) Compounds having fungicidal activity and processes to make and use same
HK1051193A1 (en) (1,4')-Bipiperidine compounds.
BR9916798A (pt) 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek
DE69829846D1 (de) Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität
HK1053603A1 (en) Medicament based on gestagens for dermal application comprising ascorbic acid and/or salts thereof
ZA200006042B (en) Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections.
MX9700696A (es) Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
MY134880A (en) Thiazolyl amide derivatives
SI1197223T1 (xx)
IL158735A0 (en) Novel ligand for nicotinic acetylcholine receptors useful in therapy
HUP0101958A3 (en) Enhancement oxazolidinone antibacterial agents activity by using arginine derivatives
ATE248822T1 (de) Partikel mit kontrollierter freisetzungsrate
BG104447A (en) Biphenylamidine derivatives
TR199901017A2 (xx) B�cek ilac� terkibi.
PT896822E (pt) 4-aminopirrolo (3,2-d)pirimidinas como antagonistas do receptor de neuropeptideo y
PT1619185E (pt) Derivado de 4,4-difluoro-1,2,3,4-tetra-hidro-5h-1-benzazepina ou um seu sal
WO2001011968A3 (en) Heterocyclic spiro compounds as pesticides
ZA200408029B (en) Novel 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors.
HU0000307D0 (en) Neuropeptide y antagonists
MXPA05009243A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados.
SI1086695T1 (en) Antiviral compositions comprising yohimbine as active principle
ZA9925B (en) Package for stacked, adhesively attachable disposable absorbent articles.
MXPA04000581A (es) Derivados de 2 -(aminometil) -tetrahidro-9 -oxa-1, 3-diaza-ciclopenta [a] -naftalenilo con actividad antipsicotica.